CD44 and cancer: Using EpCAM as an additional cell surface marker, CD44+/CD24−/low/EpCAM+ cells were demonstrated to be a more refined subpopulation with cancer stem cell properties, such as higher tumorigenic potential, self-renewal ability and tumorsphere formation [6].